Previous study have found canagliflozin could inhibited cyclin A in HUVECs [25], or induced G2/M arrest in hepatocellular carcinoma [13], or induced G1/G0 phase arrest in breast cancer [14]. The gene discussed is CCNA2; the disease is breast carcinoma.